Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
The ESO Refresher Course on Melanoma is a comprehensive, multidisciplinary programme taking place 16–18 September 2026 in Bucharest, Romania. Designed for medical oncologists, dermatologists, surgical oncologists, pathologists, radiologists, radiation oncologists, […]
The ESO Master in Sarcoma is a 15-month academic programme developed by the European School of Oncology in collaboration with the Università Campus Bio-Medico di Roma, designed to advance the […]
The ESO-EONS Masterclass in Oncology Nursing is a multi-professional programme taking place 6–10 November 2026 in San Servolo, Venice, Italy. Chaired by M. Hellberg-Naegele (Switzerland) and coordinated by T. Pehlivan […]
